Evidence map›Paper›PMID 29238602›Full record

ArticleLupus science & medicine2017

Single-cell gene expression patterns in lupus monocytes independently indicate disease activity, interferon and therapy.

Zhongbo Jin, Wei Fan, Mark A Jensen, Jessica M Dorschner, George F Bonadurer, Danielle M Vsetecka, Shreyasee Amin, Ashima Makol, Floranne Ernste, Thomas Osborn and 3 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Lupus science & medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Molecular "omic" signatures in systemic sclerosis.European journal of rheumatology · 2020
    Review
  15. Article
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Zhongbo JinDepartment of Immunology, Mayo Clinic, Rochester, Minnesota, USA.
Wei FanDepartment of Immunology, Mayo Clinic, Rochester, Minnesota, USA.
Mark A JensenDepartment of Immunology, Mayo Clinic, Rochester, Minnesota, USA.
Jessica M DorschnerDepartment of Immunology, Mayo Clinic, Rochester, Minnesota, USA.
George F BonadurerDepartment of Immunology, Mayo Clinic, Rochester, Minnesota, USA.
Danielle M VseteckaDepartment of Immunology, Mayo Clinic, Rochester, Minnesota, USA.
Shreyasee AminDivision of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA.
Ashima MakolDivision of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA.
Floranne ErnsteDivision of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA.
Thomas OsbornDivision of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA.
Kevin ModerDivision of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA.
Vaidehi ChowdharyDivision of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA.
Timothy B NiewoldDepartment of Immunology, Mayo Clinic, Rochester, Minnesota, USA.
WinnMed · USMayo Clinic · USCenter for Rheumatology · USRenji Hospital · CN

Funding

Interferon Regulatory Factor 5 in Human Lupus PathogenesisR01AR065964 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI NIEWOLD, TIMOTHY B · 2015 to 2018
$2.0M
Interferon Alpha as a Tool for Gene Discovery in Human LupusR01AR060861 · NIAMS · UNIVERSITY OF CHICAGO · PI NIEWOLD, TIMOTHY B · 2011 to 2015
$1.8M
The Role of IL-17 Axis in Inflammatory MyositisR01AR057781 · NIAMS · MAYO CLINIC ROCHESTER · PI NIEWOLD, TIMOTHY B, PETERSON, ERIK J · 2010 to 2014
$1.6M
NIAID NIH HHS L30 AI071651NIAMS NIH HHS R01 AR057781NIAMS NIH HHS R01 AR060861NIAMS NIH HHS R01 AR065964
6 · The paper itself

Abstract

objectivesImportant findings can be masked in gene expression studies of mixed cell populations. We examined single-cell gene expression in SLE patient monocytes in the context of clinical and immunological features.

methodsMonocytes were purified from patients with SLE and controls, and individually isolated for single-cell gene expression measurement. A panel of monocyte-related transcripts were measured in individual classical (CL) and non-classical (NCL) monocytes.

resultsAnalyses of both CL and NCL monocytes demonstrated that many genes had a lower expression rate in SLE monocytes than in controls. Unsupervised hierarchical clustering of the CL and NCL data sets demonstrated independent clusters of cells from the patients with SLE that were related to disease activity, type I interferon (IFN) and medication use. Thus, each of these factors exerted a different impact on monocyte gene expression that could be identified separately, and a number of genes correlated uniquely with disease activity. We found within-cell correlations between genes directly induced by type I IFN-induced and other non-IFN-induced genes, suggesting the downstream biological effects of type I IFN in individual human SLE monocytes which differed between CLs and NCLs.

conclusionsIn summary, single-cell gene expression in monocytes was associated with a wide range of clinical and biological features in SLE, providing much greater detail and insight into the cellular biology underlying the disease than previous mixed-cell population studies.

Indexed as

AutoimmunityCytokinesSystemic Lupus Erythematosus

Identifiers

PMID29238602
PMCPMC5724340
OpenAlexW2682879875

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.